184 related articles for article (PubMed ID: 8895017)
1. Increased endothelial nitric oxide synthase activity in the hyperemic vessels of portal hypertensive rats.
Cahill PA; Redmond EM; Hodges R; Zhang S; Sitzmann JV
J Hepatol; 1996 Sep; 25(3):370-8. PubMed ID: 8895017
[TBL] [Abstract][Full Text] [Related]
2. Enhanced nitric oxide synthase activity in portal hypertensive rabbits.
Cahill PA; Foster C; Redmond EM; Gingalewski C; Wu Y; Sitzmann JV
Hepatology; 1995 Aug; 22(2):598-606. PubMed ID: 7543437
[TBL] [Abstract][Full Text] [Related]
3. Nitric oxide synthase activity in portal-hypertensive and cirrhotic rats.
Kanwar S; Kubes P; Tepperman BL; Lee SS
J Hepatol; 1996 Jul; 25(1):85-9. PubMed ID: 8836906
[TBL] [Abstract][Full Text] [Related]
4. Evidence against a role for inducible nitric oxide synthase in the hyperdynamic circulation of portal-hypertensive rats.
Fernández M; García-Pagán JC; Casadevall M; Bernadich C; Piera C; Whittle BJ; Piqué JM; Bosch J; Rodés J
Gastroenterology; 1995 May; 108(5):1487-95. PubMed ID: 7537235
[TBL] [Abstract][Full Text] [Related]
5. NO overproduction by eNOS precedes hyperdynamic splanchnic circulation in portal hypertensive rats.
Wiest R; Shah V; Sessa WC; Groszmann RJ
Am J Physiol; 1999 Apr; 276(4):G1043-51. PubMed ID: 10198349
[TBL] [Abstract][Full Text] [Related]
6. Deletion of inducible nitric oxide synthase decreases mesenteric vascular responsiveness in portal hypertensive mice.
Bexis S; Vandeputte C; McCormick PA; Docherty JR
Eur J Pharmacol; 2004 Sep; 499(3):325-33. PubMed ID: 15381055
[TBL] [Abstract][Full Text] [Related]
7. Comparison of vascular nitric oxide production and systemic hemodynamics in cirrhosis versus prehepatic portal hypertension in rats.
Niederberger M; Ginés P; Martin PY; Tsai P; Morris K; McMurtry I; Schrier RW
Hepatology; 1996 Oct; 24(4):947-51. PubMed ID: 8855203
[TBL] [Abstract][Full Text] [Related]
8. Mesenteric vasoconstriction triggers nitric oxide overproduction in the superior mesenteric artery of portal hypertensive rats.
Tsai MH; Iwakiri Y; Cadelina G; Sessa WC; Groszmann RJ
Gastroenterology; 2003 Nov; 125(5):1452-61. PubMed ID: 14598261
[TBL] [Abstract][Full Text] [Related]
9. Aminoguanidine reverses aortic hyporeactivity to noradrenaline in portal vein-ligated rats.
Michielsen PP; Boeckxstaens GE; Sys SU; Herman AG; Pelckmans PA
Eur J Pharmacol; 1997 Jun; 329(2-3):137-46. PubMed ID: 9226406
[TBL] [Abstract][Full Text] [Related]
10. Influence of nitric oxide synthase and cyclooxygenase blockade on expression of cyclooxygenase and hemodynamics in rats with portal hypertension.
Cao H; Xu J; Liu H; Meng FB; Qiu JF; Wu ZY
Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):564-9. PubMed ID: 17085343
[TBL] [Abstract][Full Text] [Related]
11. iNOS expression in vascular resident macrophages contributes to circulatory dysfunction of splanchnic vascular smooth muscle contractions in portal hypertensive rats.
Kajita M; Murata T; Horiguchi K; Iizuka M; Hori M; Ozaki H
Am J Physiol Heart Circ Physiol; 2011 Mar; 300(3):H1021-31. PubMed ID: 21193589
[TBL] [Abstract][Full Text] [Related]
12. Endothelial calcium-calmodulin dependent nitric oxide synthase in the in vitro vascular hyporeactivity of portal hypertensive rats.
Gadano AC; Sogni P; Yang S; Cailmail S; Moreau R; Nepveux P; Couturier D; Lebrec D
J Hepatol; 1997 Mar; 26(3):678-86. PubMed ID: 9075677
[TBL] [Abstract][Full Text] [Related]
13. Enhanced G-protein-induced relaxation in portal hypertensive rats: role of nitric oxide.
Hou MC; Cahill PA; Zhang S; Redmond EM; Sitzmann JV
Hepatology; 1997 Jul; 26(1):27-33. PubMed ID: 9214448
[TBL] [Abstract][Full Text] [Related]
14. Hyporeactivity of mesenteric resistance arteries in portal hypertensive rats.
Sogni P; Sabry S; Moreau R; Gadano A; Lebrec D; Dinh-Xuan AT
J Hepatol; 1996 Apr; 24(4):487-90. PubMed ID: 8738736
[TBL] [Abstract][Full Text] [Related]
15. Role of nitric oxide in hyporeactivity to noradrenaline of isolated aortic rings in portal hypertensive rats.
Michielsen PP; Boeckxstaens GE; Sys SU; Herman AG; Pelckmans PA
Eur J Pharmacol; 1995 Jan; 273(1-2):167-74. PubMed ID: 7537679
[TBL] [Abstract][Full Text] [Related]
16. Regulation of atrial natriuretic factor receptors in portal hypertensive rabbits.
Cahill PA; Redmond EM; Wu Y; Sitzmann JV
J Hepatol; 1996 Feb; 24(2):185-93. PubMed ID: 8907572
[TBL] [Abstract][Full Text] [Related]
17. Hemodynamic effects of urotensin II and its specific receptor antagonist palosuran in cirrhotic rats.
Trebicka J; Leifeld L; Hennenberg M; Biecker E; Eckhardt A; Fischer N; Pröbsting AS; Clemens C; Lammert F; Sauerbruch T; Heller J
Hepatology; 2008 Apr; 47(4):1264-76. PubMed ID: 18318439
[TBL] [Abstract][Full Text] [Related]
18. Role of nitric oxide synthase and cyclooxygenase in hyperdynamic splanchnic circulation of portal hypertension.
Xu J; Cao H; Liu H; Wu ZY
Hepatobiliary Pancreat Dis Int; 2008 Oct; 7(5):503-8. PubMed ID: 18842497
[TBL] [Abstract][Full Text] [Related]
19. NAD(P)H oxidase modulates angiogenesis and the development of portosystemic collaterals and splanchnic hyperaemia in portal hypertensive rats.
Angermayr B; Fernandez M; Mejias M; Gracia-Sancho J; Garcia-Pagan JC; Bosch J
Gut; 2007 Apr; 56(4):560-4. PubMed ID: 16854998
[TBL] [Abstract][Full Text] [Related]
20. Up-regulation of nNOS and associated increase in nitrergic vasodilation in superior mesenteric arteries in pre-hepatic portal hypertension.
Jurzik L; Froh M; Straub RH; Schölmerich J; Wiest R
J Hepatol; 2005 Aug; 43(2):258-65. PubMed ID: 15963596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
